Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virus

BMC Bioinformatics

Volumn 12, Issue SUPPL. 13, 2011, Pages

  Lim, See Ven ^a   Rahman, Mohd Basyaruddin A ^a,b   Tejo, Bimo A ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING AFFINITIES; COMPUTER-AIDED; DENGUE VIRUS; EDINBURGH UNIVERSITY; HOST CELLS; HUMAN PATHOGENS; METHYLTRANSFERASES; MODE OF BINDING; POTENTIAL INHIBITORS; RIBAVIRIN; S ADENOSYL L METHIONINES; SELECTION SYSTEMS; STRUCTURE-BASED; TRIPHOSPHATE; TWO APPROACHES; VIRTUAL SCREENING;

AMIDES; AMINO ACIDS; BINDING ENERGY; BINDING SITES; BIOACTIVITY; CHEMICAL COMPOUNDS; CRYSTAL STRUCTURE; RNA;

LIGANDS;

ARTHROPODA; DENGUE VIRUS;

ANTIVIRUS AGENT; CAPPED RNA; ENZYME INHIBITOR; LIGAND; METHYLTRANSFERASE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; VIRUS PROTEIN;

ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; DENGUE; DENGUE VIRUS; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HIGH THROUGHPUT SCREENING; HUMAN; METABOLISM; VIROLOGY;

ANTIVIRAL AGENTS; BINDING SITES; DENGUE; DENGUE VIRUS; ENZYME INHIBITORS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; LIGANDS; METHYLTRANSFERASES; MODELS, MOLECULAR; RNA CAPS; S-ADENOSYLHOMOCYSTEINE; S-ADENOSYLMETHIONINE; VIRAL NONSTRUCTURAL PROTEINS;

MLCS; MLOWN;

EID: 84862604276     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-12-S13-S24     Document Type: Article

References (45)

1. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998, 11(3):480-496. 88892, 9665979.
2. Ligon BL. Dengue fever and dengue hemorrhagic fever: a review of the history, transmission, treatment, and prevention. Semin Pediatr Infect Dis 2005, 16(1):60-65. 10.1053/j.spid.2004.09.013, 15685151.
3. Gratz NG. Emerging and resurging vector-borne diseases. Annu Rev Entomol 1999, 44:51-75. 10.1146/annurev.ento.44.1.51, 9990716.
4. Halstead SB. Dengue. Lancet 2007, 370(9599):1644-1652. 10.1016/S0140-6736(07)61687-0, 17993365.
5. Mackenzie JS, Gubler DJ, Petersen LR. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 2004, 10(12 Suppl):S98-109.
6. Perera R, Kuhn RJ. Structural proteomics of dengue virus. Curr Opin Microbiol 2008, 11(4):369-377. 10.1016/j.mib.2008.06.004, 2581888, 18644250.
7. Guo JT, Hayashi J, Seeger C. West Nile virus inhibits the signal transduction pathway of alpha interferon. J Virol 2005, 79(3):1343-1350. 10.1128/JVI.79.3.1343-1350.2005, 544142, 15650160.
8. Padmanabhan R, Mueller N, Reichert E, Yon C, Teramoto T, Kono Y, Takhampunya R, Ubol S, Pattabiraman N, Falgout B, et al. Multiple enzyme activities of flavivirus proteins. Novartis Found Symp 2006, 277:74-84. discussion 84-76, 251-253.
9. Podvinec M, Schwede T, Peitsch MC. Docking for neglected diseases as community efforts. Computational Structural Biology: Methods and Applications 2008, 683-704. Singapore: World Scientific Publishing, Schwede T, Peitsch MC.
10. Luzhkov VB, Selisko B, Nordqvist A, Peyrane F, Decroly E, Alvarez K, Karlen A, Canard B, Qvist J. Virtual screening and bioassay study of novel inhibitors for dengue virus mRNA cap (nucleoside-2'O)-methyltransferase. Bioorg Med Chem 2007, 15(24):7795-7802. 10.1016/j.bmc.2007.08.049, 17888664.
11. Cleaves GR, Dubin DT. Methylation status of intracellular dengue type 2 40 S RNA. Virology 1979, 96(1):159-165. 10.1016/0042-6822(79)90181-8, 111410.
12. Ray D, Shah A, Tilgner M, Guo Y, Zhao Y, Dong H, Deas TS, Zhou Y, Li H, Shi PY. West Nile virus 5'-cap structure is formed by sequential guanine N-7 and ribose 2'-O methylations by nonstructural protein 5. J Virol 2006, 80(17):8362-8370. 10.1128/JVI.00814-06, 1563844, 16912287.
13. Egloff MP, Benarroch D, Selisko B, Romette JL, Canard B. An RNA cap (nucleoside-2'-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization. Embo J 2002, 21(11):2757-2768. 10.1093/emboj/21.11.2757, 125380, 12032088.
14. Geiss BJ, Thompson AA, Andrews AJ, Sons RL, Gari HH, Keenan SM, Peersen OB. Analysis of flavivirus NS5 methyltransferase cap binding. J Mol Biol 2009, 385(5):1643-1654. 10.1016/j.jmb.2008.11.058, 2680092, 19101564.
15. Zhou Y, Ray D, Zhao Y, Dong H, Ren S, Li Z, Guo Y, Bernard KA, Shi PY, Li H. Structure and function of flavivirus NS5 methyltransferase. J Virol 2007, 81(8):3891-3903. 10.1128/JVI.02704-06, 1866096, 17267492.
16. Courageot MP, Frenkiel MP, Dos Santos CD, Deubel V, Despres P. Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum. J Virol 2000, 74(1):564-572. 10.1128/JVI.74.1.564-572.2000, 111573, 10590151.
17. Lim SP, Wen D, Yap TL, Yan CK, Lescar J, Vasudevan SG. A scintillation proximity assay for dengue virus NS5 2'-O-methyltransferase-kinetic and inhibition analyses. Antiviral Res 2008, 80(3):360-369. 10.1016/j.antiviral.2008.08.005, 18809436.
18. Benarroch D, Egloff MP, Mulard L, Guerreiro C, Romette JL, Canard B. A structural basis for the inhibition of the NS5 dengue virus mRNA 2'-O-methyltransferase domain by ribavirin 5'-triphosphate. J Biol Chem 2004, 279(34):35638-35643. 10.1074/jbc.M400460200, 15152003.
19. Morens DM. Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clin Infect Dis 1994, 19(3):500-512. 10.1093/clinids/19.3.500, 7811870.
20. Kummerer BM, Rice CM. Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles. J Virol 2002, 76(10):4773-4784. 10.1128/JVI.76.10.4773-4784.2002, 136122, 11967294.
21. Stevens AJ, Gahan ME, Mahalingam S, Keller PA. The medicinal chemistry of dengue fever. J Med Chem 2009, 52(24):7911-7926. 10.1021/jm900652e, 19739651.
22. Taylor P, Blackburn E, Sheng YG, Harding S, Hsin KY, Kan D, Shave S, Walkinshaw MD. Ligand discovery and virtual screening using the program LIDAEUS. Br J Pharmacol 2008, 153(Suppl 1):S55-67. 2268042, 18037921.
23. Hsin KY, Morgan HP, Shave SR, Hinton AC, Taylor P, Walkinshaw MD. EDULISS: a small-molecule database with data-mining and pharmacophore searching capabilities. Nucleic Acids Res 2011, 39(Database issue):D1042-1048. 3013767, 21051336.
24. Dong H, Chang DC, Xie X, Toh YX, Chung KY, Zou G, Lescar J, Lim SP, Shi PY. Biochemical and genetic characterization of dengue virus methyltransferase. Virology 2010, 405(2):568-578. 10.1016/j.virol.2010.06.039, 20655081.
25. Pang T. Vaccines for the prevention of neglected diseases--dengue fever. Curr Opin Biotechnol 2003, 14(3):332-336. 10.1016/S0958-1669(03)00061-2, 12849789.
26. Halstead SB, Deen J. The future of dengue vaccines. Lancet 2002, 360(9341):1243-1245. 10.1016/S0140-6736(02)11276-1, 12401270.
27. Subramaniam S, Mehrotra M, Gupta D. Virtual high throughput screening (vHTS)--a perspective. Bioinformation 2008, 3(1):14-17. 10.6026/97320630003014, 2586130, 19052660.
28. Lahana R. How many leads from HTS?. Drug Discov Today 1999, 4(10):447-448. 10.1016/S1359-6446(99)01393-8, 10481138.
29. Chang MW, Lindstrom W, Olson AJ, Belew RK. Analysis of HIV wild-type and mutant structures via in silico docking against diverse ligand libraries. J Chem Inf Model 2007, 47(3):1258-1262. 10.1021/ci700044s, 17447753.
30. Kasam V, Zimmermann M, Maass A, Schwichtenberg H, Wolf A, Jacq N, Breton V, Hofmann-Apitius M. Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid. J Chem Inf Model 2007, 47(5):1818-1828. 10.1021/ci600451t, 17727268.
31. Podvinec M, Lim SP, Schmidt T, Scarsi M, Wen D, Sonntag LS, Sanschagrin P, Shenkin PS, Schwede T. Novel inhibitors of dengue virus methyltransferase: discovery by in vitro-driven virtual screening on a desktop computer grid. J Med Chem 2010, 53(4):1483-1495. 10.1021/jm900776m, 20108931.
32. Sidwell RW, Huffman JH, Khare GP, Allen LB, Witkowski JT, Robins RK. Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science 1972, 177(50):705-706. 10.1126/science.177.4050.705, 4340949.
33. Gabrielsen B, Phelan MJ, Barthel-Rosa L, See C, Huggins JW, Kefauver DF, Monath TP, Ussery MA, Chmurny GN, Schubert EM, et al. Synthesis and antiviral evaluation of N-carboxamidine-substituted analogues of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine hydrochloride. J Med Chem 1992, 35(17):3231-3238. 10.1021/jm00095a020, 1507208.
34. Crance JM, Scaramozzino N, Jouan A, Garin D. Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antiviral Res 2003, 58(1):73-79. 10.1016/S0166-3542(02)00185-7, 12719009.
35. Koff WC, Pratt RD, Elm JL, Venkateshan CN, Halstead SB. Treatment of intracranial dengue virus infections in mice with a lipophilic derivative of ribavirin. Antimicrob Agents Chemother 1983, 24(1):134-136. 185118, 6684897.
36. Olsen DB, Eldrup AB, Bartholomew L, Bhat B, Bosserman MR, Ceccacci A, Colwell LF, Fay JF, Flores OA, Getty KL, et al. A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties. Antimicrob Agents Chemother 2004, 48(10):3944-3953. 10.1128/AAC.48.10.3944-3953.2004, 521892, 15388457.
37. Milani M, Mastrangelo E, Bollati M, Selisko B, Decroly E, Bouvet M, Canard B, Bolognesi M. Flaviviral methyltransferase/RNA interaction: structural basis for enzyme inhibition. Antiviral Res 2009, 83(1):28-34. 10.1016/j.antiviral.2009.03.001, 19501254.
38. Vedel M, Lawrence F, Robert-Gero M, Lederer E. The antifungal antibiotic sinefungin as a very active inhibitor of methyltransferases and of the transformation of chick embryo fibroblasts by Rous sarcoma virus. Biochem Biophys Res Commun 1978, 85(1):371-376. 10.1016/S0006-291X(78)80052-7, 217377.
39. Yebra MJ, Sanchez J, Martin CG, Hardisson C, Barbes C. The effect of sinefungin and synthetic analogues on RNA and DNA methyltransferases from Streptomyces. J Antibiot (Tokyo) 1991, 44(10):1141-1147.
40. Lim SP, Sonntag LS, Noble C, Nilar SH, Ng RH, Zou G, Monaghan P, Chung KY, Dong H, Liu B, et al. Small molecule inhibitors that selectively block dengue virus methyltransferase. J Biol Chem 2011, 286(8):6233-6240. 10.1074/jbc.M110.179184, 3057852, 21147775.
41. Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010, 31(2):455-461. 3041641, 19499576.
42. Han LY, Lin HH, Li ZR, Zheng CJ, Cao ZW, Xie B, Chen YZ. PEARLS: program for energetic analysis of receptor-ligand system. J Chem Inf Model 2006, 46(1):445-450. 10.1021/ci0502146, 16426079.
43. Wallace AC, Laskowski RA, Thornton JM. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 1995, 8(2):127-134. 10.1093/protein/8.2.127, 7630882.
44. Shave SR. The development of high performances structure and ligand based virtual screening techniques. PhD Thesis 2009, Edinburgh: University of Edinburgh.
45. Morris GM, Huey R, Olson AJ. Using AutoDock for ligand-receptor docking. Curr Protoc Bioinformatics 2008, Chapter 8(Unit 8):14.